Buys
Open market- Shares
- Avg price
- Total value
Larry Todd Edwards - Reporting Person's title: EVP, Chief Commercial Officer at Arcutis Biotherapeutics, Inc.
Issuer-level insider activity
- Role
- Reporting Person's title: EVP, Chief Commercial Officer
- Issuer ticker
- ARQT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Larry Todd Edwards in Arcutis Biotherapeutics, Inc.
Sells
Open market- Shares
- -39,374
- Avg price
- $24.59
- Total value
- -$968,360
Net
Past year- Shares
- -39,374
- Share %
- -100%
- Total value
- -$968,360
Reported holdings for Larry Todd Edwards in Arcutis Biotherapeutics, Inc.
Form 4 holding
Reporting Person's title: EVP, Chief Commercial Officer
Arcutis Biotherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 175,178
- Estimated value
- $4,539,720
- Report date
- 02 Mar 2026
- Price
- $25.91
- Ownership
- Direct
Form 4 holding
Reporting Person's title: EVP, Chief Commercial Officer
Arcutis Biotherapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 77,000
- Estimated value
- Report date
- 27 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Larry Todd Edwards in Arcutis Biotherapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.